L-696229

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H18N2O2
Molecular Weight	282.337
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCC1=C(C)NC(=O)C(CCC2=NC3=C(O2)C=CC=C3)=C1

InChI

InChIKey=MHUVLRNBDLFMHQ-UHFFFAOYSA-N

InChI=1S/C17H18N2O2/c1-3-12-10-13(17(20)18-11(12)2)8-9-16-19-14-6-4-5-7-15(14)21-16/h4-7,10H,3,8-9H2,1-2H3,(H,18,20)

HIDE SMILES / InChI

Molecular Formula	C17H18N2O2
Molecular Weight	282.337
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:05:46 GMT 2025` Edited by `admin` on `Mon Mar 31 18:05:46 GMT 2025`
Record UNII	I3C7FZT2V8
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

L-696,229

Preferred Name

English

L-696229

Code

English

2(1H)-PYRIDINONE, 3-(2-(2-BENZOXAZOLYL)ETHYL)-5-ETHYL-6-METHYL-

Common Name

English

3-(2-(2-BENZOXAZOLYL)ETHYL)-5-ETHYL-6-METHYL-2(1H)-PYRIDINONE

Common Name

English

Code System Code Type Description

FDA UNII

I3C7FZT2V8

Created by admin on Mon Mar 31 18:05:46 GMT 2025 , Edited by admin on Mon Mar 31 18:05:46 GMT 2025

PRIMARY

PUBCHEM

72352

Created by admin on Mon Mar 31 18:05:46 GMT 2025 , Edited by admin on Mon Mar 31 18:05:46 GMT 2025

PRIMARY

EPA CompTox

DTXSID90159450

Created by admin on Mon Mar 31 18:05:46 GMT 2025 , Edited by admin on Mon Mar 31 18:05:46 GMT 2025

PRIMARY

CAS

135525-71-2

Created by admin on Mon Mar 31 18:05:46 GMT 2025 , Edited by admin on Mon Mar 31 18:05:46 GMT 2025

PRIMARY

Related Record Type Details


					A3Z87NSO0U

HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 POLYMERASE

TARGET -> INHIBITOR

Qualification:

IC50

Amount:

Related Record Type Details


					Y2LBB5G4QM

L 697895

METABOLITE -> PARENT

Qualification:

PLASMA; URINE


					357F6OUB1U

2(1H)-PYRIDINONE, 3-(2-(2-BENZOXAZOLYL)ETHYL)-5-ETHENYL-6-METHYL-

METABOLITE -> PARENT

Qualification:

PLASMA; URINE


					691N7N7EK2

2(1H)-PYRIDINONE, 3-(2-(2-BENZOXAZOLYL)ETHYL)-5-ETHYL-6-(HYDROXYMETHYL)-

METABOLITE -> PARENT

Qualification:

PLASMA; URINE


					UF2G8Q9NBW

2(1H)-PYRIDINONE, 5-ETHYL-3-(2-(6-HYDROXY-2-BENZOXAZOLYL)ETHYL)-6-METHYL-

METABOLITE -> PARENT

Qualification:

PLASMA


					HL4CGF9X3M

2(1H)-PYRIDINONE, 5-ACETYL-3-(2-(6-HYDROXY-2-BENZOXAZOLYL)ETHYL)-6-METHYL-

METABOLITE -> PARENT

Qualification:

URINE


					72XXD6GT83

3-PYRIDINEPROPANAMIDE, 5-ETHYL-1,2-DIHYDRO-N-(2-HYDROXYPHENYL)-6-METHYL-2-OXO-

METABOLITE -> PARENT

Qualification:

PLASMA; URINE


					N4HK5D83WH

2(1H)-PYRIDINONE, 3-(2-(2-BENZOXAZOLYL)ETHYL)-5-(1-HYDROXYETHYL)-6-(HYDROXYMETHYL)-

METABOLITE -> PARENT

Qualification:

URINE


					TSE9QC42M2

2(1H)-PYRIDINONE, 3-(2-(2-BENZOXAZOLYL)ETHYL)-5-ETHYL-5,6-DIHYDRO-5,6-DIHYDROXY-6-METHYL-

METABOLITE -> PARENT

Qualification:

PLASMA